Abeona Therapeutics to Present Data for ABO-401 in Cystic Fibrosis and Retinal Disorders at the American Society of Gene and Cell Therapy Annual Meeting Apr 15, 2019
Abeona Therapeutics Receives FDA Fast Track Designation for ABO-101 for Treatment of Sanfilippo Syndrome Type B (MPS IIIB) Apr 4, 2019
Abeona Therapeutics Announces Participation in 8th Annual SVB Leerink Global Healthcare Conference Feb 22, 2019
Abeona Therapeutics to Present New Supportive Data for Novel Gene Therapies at WORLDSymposium™ Jan 31, 2019
Abeona Therapeutics Details Pathway for Advancing Lead Clinical Programs and Unveils New Cystic Fibrosis Program Born from Next Generation AIM™ Vector Platform at 2018 R&D Day Dec 6, 2018
